A significant discovery in cancer research is arising with the use of VHH fragments to re-engage mutated p53. This essential malignant protector protein is frequently inactivated in many kinds of tumors, resulting https://bookmarkingbay.com/story21919609/nanobodies-reactivate-the-p53-protein-new-new-hope-for-cancer-therapy